Yubo International Biotech Limited Stock
Equities
YBGJ
US9883661004
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8 USD | -11.10% | 0.00% | +166.67% |
Financials (USD)
Sales 2022 | 0.1 | Sales 2023 | 0.6 | Capitalization | 35.95M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | -1M | EV / Sales 2022 | 116,560,264 x |
Net Debt 2022 | 772K | Net Debt 2023 | 386K | EV / Sales 2023 | 60,084,725 x |
P/E ratio 2022 |
-9.36
x | P/E ratio 2023 |
-30.1
x | Employees | 18 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.63% |
1 day | -11.10% | ||
Current month | +129.42% | ||
1 month | -15.79% | ||
3 months | +166.67% | ||
6 months | +129.23% | ||
Current year | +166.67% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.8 | -11.10% | 8,689 |
24-05-16 | 0.8999 | -2.17% | 28,678 |
24-05-15 | 0.9199 | +8.25% | 4,400 |
24-05-14 | 0.8498 | -2.88% | 4,512 |
24-05-13 | 0.875 | +9.37% | 11,110 |
Delayed Quote OTC Markets, May 17, 2024 at 12:57 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+166.67% | 95.86M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- YBGJ Stock